Orthopedic Surgery Doctors in Youngstown, OH Accepting Medicare

26 Orthopedic Surgery doctors found. Showing 1 - 20

Daniel Paul Sabo, Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-7142

Dr. John K Sontich, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-3990    Fax: 330-480-3522

Dr. James D Solmen, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8591 Crossroads Drive, Youngstown, OH 44514 Phone: 330-758-0577    Fax: 330-758-0466

Fred Vilson, Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-7142

Dr. David Weimer, MD Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8591 Crossroads Drive, Youngstown, OH 44514 Phone: 330-758-0577    Fax: 330-758-0466

Kolin Korth, DO Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-7142

Dr. Michael P Stanich, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7067 Tiffany Blvd, Suite 150, Youngstown, OH 44514 Phone: 330-726-9077    Fax: 330-726-8715

Tyson Thomas Schrickel, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-3990

Dr. Karl Seth Kuwik, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8591 Crossroads Drive, Youngstown, OH 44514 Phone: 330-758-0577    Fax: 330-758-0466

Tyler Ames, M.D. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1335 Belmont Ave, Youngstown, OH 44504 Phone: 330-729-8150

Dr. Milo Sanda Jr., DO Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Medicare Enrolled Practice Location: 8591 Crossroads Drive, Youngstown, OH 44514 Phone: 330-758-0577

Benoit Kindo, Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-7142    Fax: 330-480-2187

Nicholas Accurso, Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1001 Covington St, Youngstown, OH 44510 Phone: 330-480-2616

Dr. Anthony Stephen Berdis, D.O. Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 8591 Crossroads Drive, Youngstown, OH 44514 Phone: 330-758-0577    Fax: 330-758-0466

Andrew James Metz, DO Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-7142

Dr. James P Jamison, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8591crossroads Drive, Youngstown, OH 44514 Phone: 330-758-0577    Fax: 330-758-0466

Dr. James T Kerrigan, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8591 Crossroads Drive, Youngstown, OH 44514 Phone: 330-758-0577    Fax: 330-758-0466

Dr. Thomas A Joseph, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8591 Crossroads Drive, Youngstown, OH 44514 Phone: 330-758-0577    Fax: 330-758-0466

Dr. Joseph M Stefko, M.D. Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 8591 Crossroads Drive, Youngstown, OH 44514 Phone: 330-758-0577    Fax: 330-758-0466

Raymond Scott Duffett, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1335 Belmont Ave, Youngstown, OH 44504 Phone: 330-747-2700    Fax: 330-747-2211

News Archive

Promising clinical data of ImmunoGen's lorvotuzumab mertansine to be presented at ESMO conference

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's lorvotuzumab mertansine (IMGN901) targeted anticancer compound at the 35th European Society for Medical Oncology (ESMO) Conference being held in Milan, Italy, October 8-12, 2010.

UT Arlington scientists explore how fluid flow could play significant role in neuronal growth

A University of Texas at Arlington team exploring how neuron growth can be controlled in the lab and, possibly, in the human body has published a new paper in Nature Scientific Reports on how fluid flow could play a significant role.

CapsuleTech recognized with 2015 Global Frost & Sullivan Award for Customer Value Leadership

Based on its recent analysis of the medical device integration solutions market, Frost & Sullivan recognizes CapsuleTech with the 2015 Global Frost & Sullivan Award for Customer Value Leadership. CapsuleTech's vendor-agnostic SmartLinx medical device information system (MDIS) has emerged as a valuable data management solution that ties together the medical devices across a healthcare enterprise into a unified system that not only captures and distributes patient clinical data, but also makes available operational data about the devices themselves.

Australia ranks near top when it comes to alcohol abuse: Study

In a new study researchers have found that Australia ranks near the top when it comes to alcohol abuse. The study was conducted by the National Drug and Alcohol Research Centre (NDARC) and it found that one in five Australians has a drinking problem and four in five go untreated for these problems. Professor Maree Teesson and her team analyzed data collected from almost 9,000 Australians aged 16 to 85 years for the National Survey of Mental Health and Wellbeing in 2007.

SV40 does not have a role in the majority of malignant mesotheliomas

SV40 does not have a role in the majority of malignant mesotheliomas - a cancer associated with exposure to asbestos – according to a study in this month's Cancer Research. The study, led by Mount Sinai School of Medicine researchers used a scrupulous protocol that eliminated contamination that has likely been the reason previous studies have implicated SV40 in this cancer.

Read more Medical News

› Verified 6 days ago

• 1(current)
• 2